BE650919A - - Google Patents
Info
- Publication number
- BE650919A BE650919A BE650919DA BE650919A BE 650919 A BE650919 A BE 650919A BE 650919D A BE650919D A BE 650919DA BE 650919 A BE650919 A BE 650919A
- Authority
- BE
- Belgium
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/29—Saturated compounds containing keto groups bound to rings
- C07C49/313—Saturated compounds containing keto groups bound to rings polycyclic
- C07C49/323—Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29723363A | 1963-07-24 | 1963-07-24 | |
| US376259A US3352912A (en) | 1963-07-24 | 1964-06-18 | Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE650919A true BE650919A (xx) | 1964-11-16 |
Family
ID=26970055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE650919D BE650919A (xx) | 1963-07-24 | 1964-07-23 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3352912A (xx) |
| AT (1) | AT279581B (xx) |
| BE (1) | BE650919A (xx) |
| BR (1) | BR6460975D0 (xx) |
| CH (2) | CH476673A (xx) |
| DE (3) | DE1793208A1 (xx) |
| DK (3) | DK112027B (xx) |
| ES (1) | ES302369A1 (xx) |
| FI (3) | FI42322B (xx) |
| FR (1) | FR1572956A (xx) |
| GB (1) | GB1069563A (xx) |
| IL (1) | IL21753A (xx) |
| NL (2) | NL6408505A (xx) |
| SE (3) | SE321924B (xx) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1294371B (de) * | 1966-12-21 | 1969-05-08 | Penicillin Ges Dauelsberg & Co | Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten |
| FR2034451A1 (xx) * | 1969-01-02 | 1970-12-11 | Philips Nv | |
| DE1668571A1 (de) * | 1967-01-23 | 1971-04-15 | Du Pont | Herstellung von 2-Methylpolycyclomethylaminen |
| WO2003041707A1 (en) * | 2001-11-16 | 2003-05-22 | Astrazeneca Ab | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| US6949539B2 (en) | 2000-06-07 | 2005-09-27 | Astrazeneca Ab | Admantane derivatives |
| US7227038B2 (en) | 2003-02-21 | 2007-06-05 | Astrazeneca Ab | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| US7408065B2 (en) | 2003-06-02 | 2008-08-05 | Astrazeneca Ab | P2X7 receptor antagonists and their use |
| US7964616B2 (en) | 2007-03-22 | 2011-06-21 | Astrazeneca Ab | Compounds 679 |
| US8106073B2 (en) | 2007-11-30 | 2012-01-31 | Astrazeneca Ab | Quinoline derivatives 057 |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3449422A (en) * | 1966-02-09 | 1969-06-10 | Smithkline Corp | Pentacycloundecane amines |
| US3682922A (en) * | 1969-01-16 | 1972-08-08 | Searle & Co | N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines |
| JPS4828903B1 (xx) * | 1969-07-19 | 1973-09-05 | ||
| US3624086A (en) * | 1969-11-10 | 1971-11-30 | Searle & Co | Adamantanecarboxamidoalkanoic acid amides |
| US3852339A (en) * | 1970-06-15 | 1974-12-03 | Squibb & Sons Inc | Aminoalkoxyphenylurea derivatives |
| US3879400A (en) * | 1973-11-16 | 1975-04-22 | Upjohn Co | 1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation |
| JPS5346950A (en) * | 1976-10-12 | 1978-04-27 | Kao Corp | (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation |
| US4351847A (en) * | 1981-06-26 | 1982-09-28 | Pennwalt Corporation | Antiviral alpha, alpha-dialkyl adamantylethylamines |
| US4551552A (en) * | 1984-05-23 | 1985-11-05 | E. I. Du Pont De Nemours And Company | Process for preparing rimantadine |
| US4751245A (en) * | 1986-06-25 | 1988-06-14 | E. R. Squibb & Sons, Inc. | Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same |
| US5576355A (en) * | 1993-06-04 | 1996-11-19 | Mobil Oil Corp. | Diamondoid derivatives for pharmaceutical use |
| US5684024A (en) * | 1996-01-25 | 1997-11-04 | Viropharma Incorporated | Pyrazole dimers compositions and methods for treating influenza |
| US5821243A (en) | 1996-07-22 | 1998-10-13 | Viropharma Incorporated | Compounds compositions and methods for treating influenza |
| DK0870757T3 (da) * | 1997-04-10 | 2002-07-15 | Pfizer | Fluorsubstituerede adamantanderivater |
| WO2003004461A1 (en) * | 2001-07-02 | 2003-01-16 | Schering Corporation | Drugs for treating viral infections |
| AU2003217676B2 (en) | 2002-02-22 | 2009-06-11 | Takeda Pharmaceutical Company Limited | Active agent delivery systems and methods for protecting and administering active agents |
| WO2004056744A1 (en) * | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| EP2314574A1 (en) * | 2005-06-17 | 2011-04-27 | Apogee Biothechnology Corporation | Sphingosine kinase inhibitors |
| AR057623A1 (es) | 2005-11-28 | 2007-12-05 | Omega Bio Pharma H K Ltd | Materiales y metodos para el tratamiento de las infecciones virales |
| AU2013340559B2 (en) | 2012-10-29 | 2018-03-15 | Cipla Limited | Antiviral phosphonate analogues and process for preparation thereof |
| CA2930085C (en) * | 2013-12-09 | 2021-11-02 | Unilever Plc | Process of making adamantanamides |
| WO2017093354A1 (en) | 2015-11-30 | 2017-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nmdar antagonists for the treatment of diseases associated with angiogenesis |
| US11548893B2 (en) | 2017-07-15 | 2023-01-10 | Arisan Therapeutics Inc. | Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection |
-
1964
- 1964-06-18 US US376259A patent/US3352912A/en not_active Expired - Lifetime
- 1964-07-18 DE DE19641793208 patent/DE1793208A1/de active Pending
- 1964-07-18 DE DE19641793207 patent/DE1793207A1/de active Pending
- 1964-07-18 DE DE19641792295 patent/DE1792295B1/de not_active Withdrawn
- 1964-07-20 BR BR160975/64A patent/BR6460975D0/pt unknown
- 1964-07-20 CH CH946964A patent/CH476673A/de not_active IP Right Cessation
- 1964-07-20 CH CH1457468A patent/CH479535A/de not_active IP Right Cessation
- 1964-07-23 BE BE650919D patent/BE650919A/xx unknown
- 1964-07-23 ES ES0302369A patent/ES302369A1/es not_active Expired
- 1964-07-23 SE SE8987/64A patent/SE321924B/xx unknown
- 1964-07-23 SE SE9752/67A patent/SE320363B/xx unknown
- 1964-07-23 IL IL21753A patent/IL21753A/xx unknown
- 1964-07-23 SE SE09751/67A patent/SE330693B/xx unknown
- 1964-07-23 DK DK367964AA patent/DK112027B/da unknown
- 1964-07-23 FI FI1584/64A patent/FI42322B/fi active
- 1964-07-24 FR FR1572956D patent/FR1572956A/fr not_active Expired
- 1964-07-24 NL NL6408505A patent/NL6408505A/xx unknown
- 1964-08-04 GB GB30940/64A patent/GB1069563A/en not_active Expired
- 1964-08-07 AT AT06819/68A patent/AT279581B/de not_active IP Right Cessation
-
1965
- 1965-07-09 DK DK353265AA patent/DK114769B/da unknown
- 1965-07-09 DK DK353365AA patent/DK114199B/da unknown
-
1969
- 1969-01-22 FI FI0197/69A patent/FI42548B/fi active
- 1969-01-22 FI FI0198/69A patent/FI42211B/fi active
-
1971
- 1971-02-17 NL NL7102097A patent/NL7102097A/xx unknown
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1294371B (de) * | 1966-12-21 | 1969-05-08 | Penicillin Ges Dauelsberg & Co | Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten |
| DE1668571A1 (de) * | 1967-01-23 | 1971-04-15 | Du Pont | Herstellung von 2-Methylpolycyclomethylaminen |
| FR2034451A1 (xx) * | 1969-01-02 | 1970-12-11 | Philips Nv | |
| US6949539B2 (en) | 2000-06-07 | 2005-09-27 | Astrazeneca Ab | Admantane derivatives |
| WO2003041707A1 (en) * | 2001-11-16 | 2003-05-22 | Astrazeneca Ab | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| US7129246B2 (en) | 2001-11-16 | 2006-10-31 | Astrazeneca Ab | N-adamantlmethyl derivatives and intermediates as pharmaceutical compositions and processes for their preparation |
| AU2002347741B2 (en) * | 2001-11-16 | 2008-03-13 | Astrazeneca Ab | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| US7227038B2 (en) | 2003-02-21 | 2007-06-05 | Astrazeneca Ab | Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| US7408065B2 (en) | 2003-06-02 | 2008-08-05 | Astrazeneca Ab | P2X7 receptor antagonists and their use |
| US7964616B2 (en) | 2007-03-22 | 2011-06-21 | Astrazeneca Ab | Compounds 679 |
| US8106073B2 (en) | 2007-11-30 | 2012-01-31 | Astrazeneca Ab | Quinoline derivatives 057 |
Also Published As
| Publication number | Publication date |
|---|---|
| DK114769B (da) | 1969-08-04 |
| SE330693B (xx) | 1970-11-30 |
| CH476673A (de) | 1969-08-15 |
| DE1468769B1 (de) | 1972-06-29 |
| FR1572956A (xx) | 1969-07-04 |
| NL6408505A (xx) | 1965-01-25 |
| FI42548B (xx) | 1970-06-01 |
| NL7102097A (xx) | 1971-05-25 |
| DK112027B (da) | 1968-11-04 |
| DE1792295B1 (de) | 1971-05-27 |
| FI42211B (xx) | 1970-03-02 |
| US3352912A (en) | 1967-11-14 |
| DE1793207A1 (de) | 1972-03-30 |
| BR6460975D0 (pt) | 1973-08-09 |
| SE320363B (xx) | 1970-02-09 |
| FI42322B (xx) | 1970-03-31 |
| SE321924B (xx) | 1970-03-23 |
| ES302369A1 (es) | 1965-03-16 |
| CH479535A (de) | 1969-10-15 |
| IL21753A (en) | 1968-01-25 |
| GB1069563A (en) | 1967-05-17 |
| AT279581B (de) | 1970-03-10 |
| DK114199B (da) | 1969-06-09 |
| DE1793208A1 (de) | 1972-04-06 |